Dual Therapy Appears Superior to Monotherapy for Low-Income Individuals With Newly Diagnosed Type 2 Diabetes.

Elizabeth M VaughanCraig A JohnstonDavid J HymanDaphne C HernandezVagish HemmigeJohn P Foreyt

Published in: Journal of primary care & community health (2017)

Initiation of dual therapy was superior to metformin monotherapy or transitioning therapies and may be preferred for low-income individuals with newly diagnosed T2D.

Keyphrases

newly diagnosed
type diabetes
combination therapy
open label
cardiovascular disease
stem cells
glycemic control
adipose tissue
cell therapy
skeletal muscle